Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
Immunoprecise Antibodies Ltd (IPA)
CorMedix Inc. (CRMD)
New Form 8-K - CorMedix Inc. Filed: 2025-09-02 AccNo: 0001213900-25-082956 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of …
Repligen Corporation (RGEN)
New Form 8-K - REPLIGEN CORP Filed: 2025-09-02 AccNo: 0001193125-25-193481 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Anixa Biosciences Inc. (ANIX)
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Innate Pharma (IPHYF)
Genprex Inc. (GNPX)
Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Omeros Corporation (OMER)
Omeros Announces Publication Highlighting Survival Outcomes in TA-TMA Patients Treated with Narsoplimab Under Its Global Expanded Access Program
Medtronic plc. (MDT)
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
NRx Pharmaceuticals Inc (NRXP)
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
Neurosense Therapeutics Ltd (NRSNW)
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics Requests Type A Meeting with FDA
GSK plc (GLAXF)
Lantheus Holdings Inc. (LNTH)
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference